CAMBRIDGE, Mass., Aug. 25, 2022 -- Aktis Oncology, a biotechnology company discovering and developing novel classes of targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced...
Art Pappas will be on a panel titled "Update on Capital Availability for Indiana Companies" at Burrill's Indiana Life Sciences Forum in Indianapolis, IN
News | 10. 21. 2008
